{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:38:09Z","timestamp":1761514689109,"version":"3.40.5"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Previous studies have evaluated the risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and the biomarkers of AAV for predicting relapse. However, little is known about the association between the presence of sinusitis and relapse and changes in the ANCA levels in AAV. This single-center, retrospective cohort study included 104 consecutive patients who were newly diagnosed with myeloperoxidase (MPO)-ANCA-positive microscopic polyangiitis (MPA) between 2006 and 2018 and were treated at the Aichi Medical University Hospital in Japan. The relationships between sinusitis and relapse of vasculitis and elevated MPO-ANCA levels were assessed using multivariate Cox proportional hazards models that were adjusted for clinically relevant factors. During the entire follow-up period (median, 24 months; interquartile range, 7\u201354 months), 93 (89.4%) patients achieved remission. After achieving remission, 38 (40.9%) patients experienced at least one relapse (13 [65.0%] in the sinusitis group; 25 [34.3%] in the non-sinusitis group). Sinusitis was identified as a significant predictor of relapse (adjusted hazard ratio: 2.41, 95% confidence interval [CI]: 1.19\u20134.88; P = 0.015). Furthermore, sinusitis was more likely to be associated with elevated MPO-ANCA levels (adjusted hazard ratio: 2.59, 95% CI: 1.14\u20135.92; P = 0.024). In conclusion, sinusitis was associated with a higher risk of relapse and elevated MPO-ANCA levels in MPA patients, suggesting that careful management may be required to reduce the risk of relapse in patients with sinusitis. Further studies are needed to elucidate the optimal treatment strategy for these patients.<\/jats:p>","DOI":"10.1371\/journal.pone.0243572","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T19:20:12Z","timestamp":1607628012000},"page":"e0243572","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between sinusitis and relapse and changes in the myeloperoxidase\u2013antineutrophil cytoplasmic antibody in microscopic polyangiitis"],"prefix":"10.1371","volume":"15","author":[{"given":"Hiroya","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Iwagaitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Nobata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kinashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Banno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-6961","authenticated-orcid":true,"given":"Yasuhiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"pone.0243572.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"JC Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"pone.0243572.ref002","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2215\/CJN.06250519","article-title":"Treatment of relapses in ANCA-associated vasculitis","volume":"14","author":"M McClure","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0243572.ref003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2013.06.002","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis","volume":"62","author":"L Beck","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"pone.0243572.ref004","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"M Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"pone.0243572.ref005","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial","volume":"74","author":"RB Jones","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"pone.0243572.ref006","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"M Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"pone.0243572.ref007","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"C Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"pone.0243572.ref008","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/rheumatology\/keq244","article-title":"Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission","volume":"49","author":"C Pierrot-Deseilligny Despujol","year":"2010","journal-title":"Rheumatology"},{"key":"pone.0243572.ref009","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/art.38621","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a study of 439 cases in a single Chinese center","volume":"66","author":"ZY Li","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"pone.0243572.ref010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegener\u2019s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre","volume":"336","author":"JW Tervaert","year":"1990","journal-title":"Lancet"},{"key":"pone.0243572.ref011","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"R Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"pone.0243572.ref012","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s12879-019-4300-0","article-title":"Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"19","author":"M Yamaguchi","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pone.0243572.ref013","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00296-020-04562-z","article-title":"Association between statin use and incidence of relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-center retrospective cohort study","volume":"40","author":"M Yamaguchi","year":"2020","journal-title":"Rheumatol Int"},{"key":"pone.0243572.ref014","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"S Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"pone.0243572.ref015","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"RA Luqmani","year":"1994","journal-title":"QJM"},{"key":"pone.0243572.ref016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00005537-200301000-00023","article-title":"The accuracy of computed tomography in the diagnosis of chronic rhinosinusitis","volume":"113","author":"N Bhattacharyya","year":"2003","journal-title":"Laryngoscope"},{"key":"pone.0243572.ref017","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3899\/jrheum.141622","article-title":"Increase of antimyeloperoxidase antineutrophil cytoplasmic antibody (ANCA) in patients with renal ANCA-associated vasculitis: association with risk to relapse","volume":"42","author":"M Yamaguchi","year":"2015","journal-title":"J Rheumatol"},{"key":"pone.0243572.ref018","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"SL Hogan","year":"2005","journal-title":"Ann Intern Med"},{"key":"pone.0243572.ref019","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10238-020-00614-7","article-title":"Risk factors for treatment resistance and relapse of Chinese patients with MPO-ANCA-associated vasculitis","volume":"20","author":"L Huang","year":"2020","journal-title":"Clin Exp Med"},{"key":"pone.0243572.ref020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3899\/jrheum.170508","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis in Japan: a nationwide, prospective cohort study","volume":"45","author":"A Hara","year":"2018","journal-title":"J Rheumatol"},{"key":"pone.0243572.ref021","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2014a meta-analysis.","volume":"51","author":"G Tomasson","year":"2012","journal-title":"Rheumatology"},{"key":"pone.0243572.ref022","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40538","article-title":"Association between reappearance of myeloperoxidase-antineutrophil cytoplasmic antibody and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: subgroup analysis of nationwide prospective cohort studies","volume":"70","author":"H Watanabe","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"pone.0243572.ref023","first-page":"7","article-title":"Relapse in anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis","volume":"24","author":"AD Salama","year":"2019","journal-title":"Kidney Int Rep"},{"key":"pone.0243572.ref024","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"MJ Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"pone.0243572.ref025","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.semnephrol.2017.05.016","article-title":"ANCA-associated vasculitis: pathogenesis, models, and preclinical testing","volume":"37","author":"HL Hutton","year":"2017","journal-title":"Semin Nephrol"},{"key":"pone.0243572.ref026","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.14626.1","article-title":"Recent advances in understanding of the pathogenesis of ANCA-associated vasculitis","volume":"7","author":"M Prendecki","year":"2018","journal-title":"F1000Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T19:20:22Z","timestamp":1607628022000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243572"}},"subtitle":[],"editor":[{"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243572","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,12,10]]}}}